Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Ablative Solutions has raised $10.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Ablative Solutions's investors include Gilde Healthcare, BioStar Capital, Invus Opportunities, CKM Capital Partners, Michigan Accelerator Fund I.
Ablative Solutions is headquartered in Wakefield, United States.
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Ablative Solutions is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ablative Solutions — Funding & Investors." VCBacked, November 26, 2025, https://www.vcbacked.co/company/ablative-solutions. Accessed July 20, 2026.
VCBacked. (2025). Ablative Solutions — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ablative-solutions
{{cite web |title=Ablative Solutions — Funding & Investors |url=https://www.vcbacked.co/company/ablative-solutions |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated